Abstract:Aim: To evaluate the characteristics and the hypoglycemic efficacy of insulin liposomes coated by chitosan-EDTA conjugates(CEC) having different degrees of modification and concentrations after oral administration in mice. Method: CEC was synthesized from chitosan. Insulin-liposomes were prepared by reversed-phase evaporation. CEC coating was carried out by mixing the liposomal suspensions with the CEC solution, followed by incubation. The morphological examination of insulin-liposomes was performed with transmission electron microscopy (TEM). The particle size and Zeta potential were analyzed by using photon correlation spectroscopy and laser doppler anemometry. The entrapment efficiency was determined with HPLC and ultracentrifuge. The protection of insulin from peptic and tryptic digestion was studied with HPLC. The hypoglycemic effects of CEC-coated insulin liposomes were investigated using the glucose oxidase method after oral administration in mice. Result: A molar ratio of 1:20(D-glucosamine subunit of chitosan: EDTA) leads to an almost quantitative modification of all free amino groups. A higher excess of EDTA during the coupling reaction did not lead to a higher degree of modification. In contrast, a lower molar ratio than 1:20 leads to a polymer conjugate of comparable higher viscosity. The Zeta potentials and the particle sizes of CEC-coated insulin-liposomes were found to be increased with increasing concentration of CEC, but slightly decreased with increasing degree of modification. The entrapment efficiencies had no obvious correlation with the degree of quaternization and the concentration of CEC. All insulin-liposomes were of spherical or ellipsoidal shape. In peptic solutions, CEC and CEC-coated liposomes had abilities of protecting insulin from peptic digestion, which were increased with increased concentration of CEC. However, the abilities of CEC-coated liposomes were slightly lower than those of CEC. In all CEC-coated liposomes, the protective action of CEC2-coated liposomes was the strongest. In tryptic solutions, CEC had the ability of protecting insulin from tryptic digestion. However, CEC-coated liposomes had no protective action of insulin, even it could enhance digestion of insulin. All CEC-coated liposomes had definite hypoglycemic effects, and the effect was found to be increased with increasing concentration of CEC. As compared with the other CEC-coated insulin liposomes, CEC2-coated insulin liposomes have better hypoglycemic effects. The minimum blood glucose was 39.3% of the initial blood glucose. The blood glucose reducing effect could last 4 h after oral administration by mice. Conclusion: Proteolytic activity of pepsin and trypsin could be inhibited by CEC. CEC-coated liposomes could enhance enteral absorption of insulin. Degree of modification and concentrations of CEC were well correlated with the hypoglycemic effect of CEC-coated insulin liposomes.

Effect of Chitosan-Cysteine Conjugate on Enzymatic Degradation and Hypoglycemic Effect of Insulin

Effects of Chitosan-EDTA Conjugates on Insulin Nano-liposomes

Studies on the Insulin-Liposomes Double-Coated by Chitosan and Chitosan-Edta Conjugates

Hypoglycemic Efficacy of Chitosan-Coated Insulin Liposomes after Oral Administration in Mice.

[Effects of the Liposomes Coated by Chitosan and Its Derivatives on the Gastrointestinal Transit of Insulin].

[Hypoglycemic Effect of Polysaccharide-Coated Insulin Liposomes after Oral Administration in Mice].

Effect of Casein and Protamine on the Enzymatic Degradation and the Orally Hypoglycemic Action of Insulin

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Effect of Liposome Double-Coated with Chitosan and Chitosan-EDTA Conjugates on Oral Absorption of Insulin

Therapeutic Effect of Carboxymethylated and Quanternized Chitosan on Insulin Resistance in High-Fat-Diet-Induced Rats and 3T3-L1 Adipocytes

Enhanced Stability of Oral Insulin in Targeted Peptide Ligand Trimethyl Chitosan Nanoparticles Against Trypsin

Effect of chitosan on transport of insulin across Caco-2 monolayer

Insulin-Loaded Soybean Trypsin Inhibitor-Chitosan Nanoparticles: Preparation, Characterization, and Protective Effect Evaluation

Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

Effects of Water-Soluble Low Molecular Chitosan on Plasma Glucose in Diabetic Rats

Chitosan-Modified Cationic Amino Acid Nanoparticles As a Novel Oral Delivery System for Insulin

Preparation and Pharmacodynamics of Low-Molecular-weight Chitosan Nanoparticles Containing Insulin

Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration

Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin

Preparation and improvement of release behavior of chitosan microspheres containing insulin.

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo